出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/02/17 11:58:11」(JST)
Isosorbide | |
---|---|
Other names
D-Isosorbide; 1,4:3,6-Dianhydro-D-sorbitol; 1,4-Dianhydrosorbitol |
|
Identifiers | |
CAS number | 652-67-5 N |
PubChem | 12597 |
ChemSpider | 12077 Y |
KEGG | D00347 Y |
ChEMBL | CHEMBL1200660 N |
Jmol-3D images | Image 1 |
SMILES
|
|
InChI
|
|
Properties | |
Molecular formula | C6H10O4 |
Molar mass | 146.14 g mol−1 |
Appearance | Colorless solid |
Melting point |
60-63 °C, 333-336 K, 140-145 °F |
Boiling point |
decomp |
N (verify) (what is: Y/N?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
Isosorbide is a heterocyclic compound that is derived from glucose. It is a white solid that is prepared from glucose. It is used in medicine and has been touted as a potential biofeedstock.
Hydrogenation of glucose gives sorbitol. Isosorbide is obtain by double dehydration or this hexa-alcohol:
An intermediate in the dehydration is the monocycle sorbitan.[1]
Isosorbide is a used as a diuretic used mainly to treat hydrocephalus and is also used to treat glaucoma.[2]
Other medications are derived from isosorbide, including isosorbide dinitrate and isosorbide mononitrate, are used to treat angina pectoris. Other isosorbide-based medicines are used as osmotic diuretics and for treatment of esophageal varices. Like other nitric oxide donors (see biological functions of nitric oxide), these drugs lower portal pressure by vasodilation and decreasing cardiac output. Isosorbide dinitrate and hydralazine are the two components of the anti-hypertensive drug isosorbide dinitrate/hydralazine (Bidil).
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
リンク元 | 「利尿薬」「イソソルビド」 |
拡張検索 | 「isosorbide dinitrate」 |
CATIONS | ANIONS | 尿酸 | 腎血液動態 | |||||||||||||
Na+ | K+ | H+ | Ca2+ | Mg2+ | Cl- | HCO3- | H2PO4- | 急性 | 慢性 | RBF | GFR | FF | TGF | |||
炭酸脱水酵素阻害薬 | 炭酸脱水酵素阻害 | 近位尿細管 |
+ | ++ | - | NC | V | (+) | ++ | ++ | I | - | - | - | NC | + |
浸透圧利尿薬 | 浸透圧 | ヘンレループ |
++ | + | I | + | ++ | + | + | + | + | I | + | NC | - | I |
ループ利尿薬 | Na+-K+-2Cl- symport阻害 | 太い上行脚 |
++ | ++ | + | ++ | ++ | ++ | +(1) | +(1) | + | - | V(+) | NC | V(-) | - |
チアジド系利尿薬 | Na+-Cl-symport阻害 | 遠位尿細管 |
+ | ++ | + | V(-) | V(+) | + | +(1) | +(1) | + | - | NC | V(-) | V(-) | NC |
カリウム保持性利尿薬 | 上皮性ナトリウムチャネル阻害 | 遠位尿細管後部と集合管 |
+ | - | - | - | - | + | (+) | NC | I | - | NC | NC | NC | NC |
アルドステロン受容体拮抗 | 遠位尿細管後部と集合管 |
+ | - | - | I | - | + | (+) | I | I | - | NC | NC | NC | NC |
.